Glucagon infusion following phosphodiesterase inhibition: an experimental study of the hemodynamic effects.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004357:Drug Synergism; D005934:Glucagon / Q000008:administration & dosage / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects*; D010726:Phosphodiesterase Inhibitors; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D010726:Phosphodiesterase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; D005934:Glucagon; D000242:Cyclic AMP